Skin of Color
Get the scoop on what will happen live at CSF 2019!
Joel Schlessinger, MD, FAAD
When surgery or RF energy isn’t an option for aging eyes, Ultherapy may play a role.
Manjula Jegasothy, MD
Sabrina Fabi, MD
Long-term IPL use may turn the tables on aging skin.
Michael Gold, MD, FAAD
Can the Myers–Briggs Type Indicator take the guess work out of your next hiring
There's a new and expanding menu of options to improve uneven tone, proving that OTCs can provide benefit for a vexing concern.
Jeanine Downie, MD
They don't call it Nash-Vegas for nothing. CSF is moving east but keeping all the key features.
Low-intensity cutaneous shockwave treatment represents a novel option for the treatment of vasculogenic ED.
David J. Goldberg, MD, JD
ICYMI: Updates from behind the scenes at the 10th Annual Cosmetic Surgery Forum.
Section editor: Joel Schlessinger, MD
Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.
A new venue and new speakers—and a fous on hot topics—will be part of CSF 2018.
Joel Schlessinger, MD
Here's the real scoop on popular oral beauty supplements.
With Matthew J. Zirwas, MD
A new laser system may make brown eyes blue.
With Julie Woodward, MD
A unique herb blend in cosmeceuticals has shown clinical superiority over antioxidant and growth factor products.
Carl R. Thornfeldt, MD, FAAD
A sneak peek at fillers heading for the US market.
With Joel Schlessinger, MD
Are cosmetic treatments too risky for patients prone to keloids?
Top cosmeceutical picks from Cosmetic Surgery Forum! From melasma therapy to sunscreen, the founder of CSF shares his favorite cosmeceuticals.
As skin of color patients proliferate, demand for pigment treatments will soar.
With Michael H. Gold, MD
What the science says about the effects of sunscreens on marine life.
Matthew J. Zirwas, MD
Knowing how to avoid and effectively manage potential complications is key to success.
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.